Serum decorin and biglycan levels as predictive biomarkers for lung fibrosis severity and mortality risk in COVID-19 patients.

Journal: Frontiers in medicine
Published Date: Jan 21, 2025

Abstract

INTRODUCTION: Individuals experiencing severe symptoms of COVID-19 are at the greatest risk of developing post-COVID lung fibrosis, which significantly impacts long-term health outcomes. This study aims to investigate the predictive potential of serum biomarkers, specifically decorin and biglycan, in assessing the severity and mortality risk among COVID-19 patients.

Authors

  • Shaaf Ahmad
    King Edward Medical University/Mayo Hospital, Lahore, Punjab, Pakistan.
  • Kaleem Maqsood
    Institute of Zoology, University of the Punjab, Lahore, Punjab, Pakistan.
  • Farwa Liaqat
    Institute of Zoology, University of the Punjab, Lahore, Punjab, Pakistan.
  • Nabila Roohi
    Institute of Zoology, University of the Punjab, Lahore, Punjab, Pakistan.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals